SEARCH

SEARCH BY CITATION

References

  1. References
  2. Selected Bibliography: Mammographic Evaluation
  3. Surgical Considerations
  4. Pathologic Evaluation
  5. Selection of Treatment
  6. Follow-Up Recommendations
  • 1
    Winchester DP, Cox JD: Standards for breast-conservation treatment. CA Cancer J Clin 1992; 42: 134162.
  • 2
    Fisher B, Costantino J, Redmond C, et al: Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993; 328: 15811586.
  • 3
    Fisher ER, Costantino J, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). Cancer 1995; 75: 13101319.
  • 4
    Mamounas E, Fisher B, Dingam J, et al: Effects of breast irradiation following lumpectomy in intraductal carcinoma (DCIS): Updated results from NSABP B-17. Proc Soc Surg Oncol 1997; 50: 7.
  • 5
    Solin LJ, Recht A, Fourquet A, et al: Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Cancer 1991; 68: 23372344.
  • 6
    Solin LJ, Kurtz J, Fourquet A, et al: Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 1996; 14: 754763.
  • 7
    McCormick B, Rosen PP, Kinne D, et al: Duct carcinoma in situ of the breast: An analysis of local control after conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1991; 21: 289292.
  • 8
    Sneige N, McNeese MD, Atkinson EN, et al: Ductal carcinoma in situ treated with lumpectomy and irradiation: Histopathological analysis of 49 specimens with emphasis on risk factors and long term results. Hum Pathol 1995; 26: 642649.
  • 9
    Solin LJ, McCormick B, Recht A, et al: Mammographically detected, clinically occult ductal carcinoma in situ (intraductal carcinoma) treated with breast conserving surgery and definitive breast irradiation. Cancer J Sci Am 1996; 2: 158165.
  • 10
    Fowble B, Hanlon AL, Fein DA, et al: Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int J Radiat Oncol Biol Phys 1996; 38: 949957.
  • 11
    Van Zee PJ, Liberman L, McCormick B, et al: Long-term follow-up of DCIS treated with breast conservation: Effect of age and radiation, in Abstract Book, Society of Surgical Oncology meeting, Atlanta, March 21–24, 1996. Arlington Heights, IL, Society of Surgical Oncology, 1996.
  • 12
    Hiramatsu H, Bornstein BA, Recht A, et al: Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history. Cancer J Sci Am 1995; 1: 5561.
  • 13
    Vicini FA, Lacerna MD, Horwitz EM, et al: Mammographically detected DCIS treated with breast conserving therapy: An analysis of clinical, pathologic, and treatment related factors affecting outcome. Int J Radiat Oncol Biol Phys 1996; 36 (Suppl): 214. Abstract.
  • 14
    Kuske RR, Bean JM, Garcia DM, et al: Breast conservation therapy for intraductal carcinoma of the breast. Int J Radiat Oncol Biol Phys 1993; 26: 391396.
  • 15
    Silverstein MJ, Lagios MD, Craig PH, et al: A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996; 77: 22672274.
  • 16
    Fourquet A, Zafrani B, Campana F: Breast conserving treatment of ductal carcinoma in situ. Semin Radiat Oncol 1992; 2: 116124.
  • 17
    Kurtz JM, Jacquemier J, Torhorst J, et al: Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 1989; 63: 16301635.
  • 18
    Ray GR, Adelson J, Hayhurst E, et al: Ductal carcinoma in situ of the breast: Results of treatment by conservative surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 1994; 28: 105111.
  • 19
    Silverstein MJ, Barth A, Poller DN, et al: Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995; 31: 14251427.
  • 20
    Haffty BG, Peschel RE, Papadopoulis D, et al: Radiation therapy for ductal carcinoma in situ of the breast. Conn Med 1990; 54: 482484.
  • 21
    Solin LJ, Fourquet A, McCormick B, et al: Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast. Int J Radiat Oncol Biol Phys 1994; 30: 39.
  • 22
    Fisher ER, Sass R, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 6): II. Relation of local breast recurrence to multicentricity. Cancer 1986; 57: 17171724.
  • 23
    Lagios MD: Duct carcinoma in situ: Biological implications for clinical practice. Semin Oncol 1996; 23 (Suppl 2): 611.
  • 24
    Lagios MD, Westdahl PR, Margolin FR, et al: Duct carcinoma in situ: Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982; 50: 13091314.
  • 25
    Lagios MD: Ductal carcinoma in situ: Controversies in diagnosis, biology, and treatment. Breast J 1995; 1: 6878.
  • 26
    Lagios MD: Lagios experience, in SilversteinMJ (ed): Ductal Carcinoma in Situ of the Breast. Baltimore, Williams & Wilkins, 1997, pp 361365.
  • 27
    Lagios MD, Margolin FR, Westdahl PR, et al: Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989; 63: 618624.
  • 28
    Lagios MD: Duct carcinoma in situ: Pathology and treatment. Surg Clin North Am 1990; 70: 853871.
  • 29
    Fentiman IS: Treatment of screen detected ductal carcinoma in situ: A silver lining within a grey cloud? Br J Cancer 1990; 61: 795796. Editorial.
  • 30
    Spittle M, Stewart HJ: Non-surgical management of early breast cancer in the United Kingdom: Ductal carcinoma in situ. Clin Oncol 1995; 7: 217218.
  • 31
    Ashikari R, Huvos AG, Synder RE: Prospective study of non-infiltrating carcinoma of the breast. Cancer 1977; 39: 435439.
  • 32
    Sunshine JA, Moseley HS, Fletcher WS, et al: Breast carcinoma in situ: A retrospective review of 112 cases with a minimum 10 year follow-up. Am J Surg 1985; 150: 4451.
  • 33
    Farrow JH: Current concepts in the detection and treatment of the earliest of the early breast cancers. Cancer 1970; 25: 468477.
  • 34
    Silverstein MJ, Cohlan BF, Gierson ED, et al: Duct carcinoma in situ: 227 cases without microinvasion. Eur J Cancer 1992; 28: 630634.
  • 35
    Von Rueden DG, Wilson RE: Intraductal carcinoma of the breast. Surg Gynecol Obstet 1984; 158: 105111.
  • 36
    Kinne DW, Petrek JA, Osborne MP, et al: Breast carcinoma in situ. Arch Surg 1989; 124: 3336.
  • 37
    Schuh ME, Nemoto T, Penetrante RB, et al: Intraductal carcinoma: Analysis of presentation, pathologic findings, and outcome of disease. Arch Surg 1986; 121: 13031307.
  • 38
    Arnesson LG, Smeds S, Fagerberg G, et al: Follow-up of two treatment modalities for ductal carcinoma in situ of the breast. Br J Surg 1989; 76: 672675.
  • 39
    Fentiman IS, Julien JP, van Dongen JA, et al: Reasons for non-entry of patients with DCIS of the breast into a randomized trial (EORTC 10853). Eur J Cancer 1991; 27: 450452.
  • 40
    Ringberg A: Accrual rate limiting factors in a Swedish randomised DCIS trial. Eur J Cancer 1994; 30A (Suppl 2): S33. Abstract.
  • 40a
    Solin LJ, Fowble BL, Schultz DJ, et al: Definitive irradiation for intraductal carcinoma of the breast. Int J Radiat Oncol Biol Phys 1990; 19: 843850.
  • 41
    Arnesson LG, Olsen K: Linkoping experience, in SilversteinMJ (ed): Ductal Carcinoma in Situ of the Breast. Baltimore, Williams & Wilkins, 1997, pp 373378.
  • 42
    Baird RM, Worth A, Hislop G: Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breast. Am J Surg 1990; 159: 479481.
  • 43
    Carpenter R, Boulter PS, Cooke T, et al: Management of screen detected ductal carcinoma in situ of the female breast. Br J Surg 1989; 76: 564567.
  • 44
    Cataliotti L, Distante V, Pacini P, et al: Florence experience, in SilversteinMJ (ed): Ductal Carcinoma in Situ of the Breast. Baltimore, Williams & Wilkins, 1997, pp 449454.
  • 45
    Eusebi V, Feudale E, Foschini MP, et al: Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 1994; 11: 223235.
  • 46
    Fisher ER, Leeming R, Anderson S, et al: Conservative management of intraductal carcinoma (DCIS) of the breast. J Surg Oncol 1991; 47: 139147.
  • 47
    Salvadori B, Delledonne V, Rovini D: National Cancer Institute-Milan experience, in SilversteinMJ (ed): Ductal Carcinoma in Situ of the Breast. Baltimore, Williams & Wilkins, 1997, pp 427432.
  • 48
    Shreer I: Conservation therapy of DCIS without radiation. Breast Dis 1996; 9: 2736.
  • 49
    Schwartz GF, Finkel GC, Garcia JC, et al: Subclinical ductal carcinoma in situ of the breast: Treatment by local excision and surveillance alone. Cancer 1992; 70: 24682474.
  • 50
    Schwartz GF: Treatment of subclinical ductal carcinoma in situ by excision and local surveillance, in SilversteinMJ (ed): Ductal Carcinoma in Situ of the Breast. Baltimore, Williams & Wilkins, 1997, pp 353360.
  • 51
    Sibbering DM, Blamey RW: Nottingham experience, in SilversteinMJ (ed): Ductal Carcinoma in Situ of the Breast. Baltimore, Williams & Wilkins, 1997, pp 367372.
  • 52
    Silverstein MJ: Van Nuys experience by treatment, in SilversteinMJ (ed): Ductal Carcinoma in Situ of the Breast. Baltimore, Williams & Wilkins, 1997, pp 443448.
  • 53
    Silverstein MJ, Poller DN, Waisman JR, et al: Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995; 345: 11541157.

Selected Bibliography: Mammographic Evaluation

  1. References
  2. Selected Bibliography: Mammographic Evaluation
  3. Surgical Considerations
  4. Pathologic Evaluation
  5. Selection of Treatment
  6. Follow-Up Recommendations

Surgical Considerations

  1. References
  2. Selected Bibliography: Mammographic Evaluation
  3. Surgical Considerations
  4. Pathologic Evaluation
  5. Selection of Treatment
  6. Follow-Up Recommendations

Pathologic Evaluation

  1. References
  2. Selected Bibliography: Mammographic Evaluation
  3. Surgical Considerations
  4. Pathologic Evaluation
  5. Selection of Treatment
  6. Follow-Up Recommendations
  • 1
    FlemingID, CooperJS, HensonDE, et al (eds): Manual for Staging of Cancer, ed 5. Philadelphia, JB Lippincott, 1997.
  • 2
    Association of Directors of Anatomic and Surgical Pathology: Immediate management of mammographically detected breast lesions. Hum Pathol 1993; 24: 689690.
  • 3
    Association of Directors of Anatomic and Surgical Pathology: Recommendations for the reporting of breast carcinoma. Mod Pathol 1996; 9: 7781.
  • 4
    Holland R, Peterse JL, Millis RR, et al: Ductal carcinoma in situ: A proposal for a new classification. Semin Diagn Pathol 1994; 11: 167180.
  • 5
    Patchefsky AS, Schwartz GF, Finkelstein SD, et al: Heterogeneity of intraductal carcinoma of the breast. Cancer 1989; 63: 731741.
  • 6
    Poller DN, Silverstein MJ, Galea M, et al: Ductal carcinoma in situ of the breast: A proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. Mod Pathol 1994; 7: 257262.
  • 7
    Schnitt SJ, Connolly JL: Processing and evaluation of breast excision specimens: A clinically oriented approach. Am J Clin Pathol 1992; 98: 125137.
  • 8
    Schnitt SJ, Silen W, Sadowsky NL, et al: Ductal carcinoma in situ (intraductal carcinoma) of the breast. New Engl J Med 1988; 318: 898903.
  • 9
    Schuh ME, Nemoto T, Penetrante RB, et al: Intraductal carcinoma: Analysis of presentation, pathologic findings, and outcome of disease. Arch Surg 1986; 121: 13031307.
  • 10
    Stomper PC, Conolly JL: Ductal carcinoma in situ of the breast: Correlation between mammographic calcification and tumor subtype. AJR Am J Roentgenol 1992; 159: 483485.

Selection of Treatment

  1. References
  2. Selected Bibliography: Mammographic Evaluation
  3. Surgical Considerations
  4. Pathologic Evaluation
  5. Selection of Treatment
  6. Follow-Up Recommendations
  • 1
    Ernster VL, Barclay J, Kerlikowske K, et al: Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996; 275: 913918.
  • 2
    Winchester DJ, Menck HR, Winchester DP: National treatment trends for ductal carcinoma in situ of the breast. Presented at the Annual Scientific Session of the Western Surgical Association; November 20, 1996; Portland, OR.
  • 3
    Bellamy Co, McDonald C, Salter DM, et al: Noninvasive ductal carcinoma of the breast: The relevance of histologic categorization. Hum Pathol 1993; 24: 1623.
  • 4
    Farrow JH: Current concepts in the detection and treatment of the earliest of the early breast cancers. Cancer 1970; 25: 468477.
  • 5
    Kinne DW, Petrek JA, Osborne MP, et al: Breast carcinoma in situ. Arch Surg 1989; 124: 3336.
  • 6
    Osteen RT, Karnell LH: The National Cancer Data Base report on breast cancer. Cancer 1994; 73: 19942000.
  • 7
    Rosen PP, Senie R, Schottenfeld D, et al: Noninvasive breast carcinoma: Frequency of unsuspected invasion and implications for treatment. Ann Surg 1979; 189: 377382.
  • 8
    Silverstein MJ, Cohlan BF, Gierson ED, et al: Duct carcinoma in situ: 227 cases without microinvasion. Eur J Cancer 1992; 28: 630634.
  • 9
    Von Rueden DG, Wilson RE: Intraductal carcinoma of the breast. Surg Gynecol Obstet 1984; 158: 105111.
  • 10
    Stotter AT, McNeese M, Oswald MJ, et al: The role of limited surgery with irradiation in primary treatment of ductal in situ breast cancer. Int J Radiat Oncol Biol Phys 1990; 18: 283287.
  • 11
    Winchester DP, Menck HR, Osteen RT, et al: Treatment trends for ductal carcinoma in situ of the breast. Ann Surg Oncol 1995; 2: 207213.
  • 12
    Fisher ER, Costantino J, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: Intraductal carcinoma (ductal carcinoma in situ). Cancer 1995; 76: 23862387. Letter.
  • 13
    Arnesson LG, Smeds S, Fagerberg G, et al: Follow-up of two treatment modalities for ductal carcinoma in situ of the breast. Br J Surg 1989; 76: 672675.
  • 14
    Ashikari R, Huvos AG, Synder RE: Prospective study of non-infiltrating carcinoma of the breast. Cancer 1977; 39: 435439.
  • 15
    Fisher ER, Sass R, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 6): II. Relation of local breast recurrence to multicentricity. Cancer 1986; 57: 17171724.
  • 16
    Fourquet A, Zafrani B, Campana F: Breast conserving treatment of ductal carcinoma in situ. Semin Radiat Oncol 1992; 2: 116124.
  • 17
    Fowble B, Hanlon AL, Fein DA, et al: Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCiS). Int J Radiat oncol Biol Phys 1997; 38: 949957.
  • 18
    Hiramatsu H, Bornstein BA, Recht A, et al: Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history. Cancer J Sci Am 1995; 1: 5561.
  • 19
    Silverstein MJ, Barth A, Poller DN, et al: Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995; 31: 14251427.
  • 20
    Sneige N, McNeese MD, Atkinson EN, et al: Ductal carcinoma in situ treated with lumpectomy and irradiation: Histopathological analysis of 49 specimens with emphasis on risk factors and long term results. Hum Pathol 1995; 26: 642649.
  • 21
    Solin LJ, Kurtz J, Fourquet A, et al: Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin oncol 1996; 14: 754763.
  • 22
    Solin LJ, McCormick B, Recht A, et al: Mammographically detected, clinically occult ductal carcinoma in situ (intraductal carcinoma) treated with breast conserving surgery and definitive breast irradiation. Cancer J Sci Am 1996; 2: 158165.
  • 23
    Sunshine JA, Moseley HS, Fletcher WS, et al: Breast carcinoma in situ: A retrospective review of 112 cases with a minimum 10 year follow-up. Am J Surg 1985; 150: 44.
  • 24
    Zafrani B, Fourquet A, Vilcoq JR, et al: Conservative management of intraductal breast cancer with tumorectomy and radiation therapy. Cancer 1986; 57: 12991301.
  • 25
    Arnesson LG, Olsen K: Linkoping experience, in SilversteinMJ (ed): Ductal Carcinoma in Situ of the Breast. Baltimore, Williams & Wilkins, 1997, pp 373378.
  • 26
    Baird RM, Worth A, Hislop G: Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breast. Am J Surg 1990; 159: 479481.
  • 27
    Carpenter R, Boulter PS, Cooke T, et al: Management of screen detected ductal carcinoma in situ of the female breast. Br J Surg 1989; 76: 564567.
  • 28
    Cataliotti L, Distante V, Pacini P, et al: Florence experience, in SilversteinMJ (ed): Ductal Carcinoma in Situ of the Breast. Baltimore, Williams & Wilkins, 1997, pp 449454.
  • 19
    Eusebi V, Feudale E, Foschini MP, et al: Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 1994; 11: 223235.
  • 30
    Fisher B, Costantino J, Redmond C, et al: Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. New Engl J Med 1993; 328: 15811586.
  • 31
    Fisher ER, Leeming R, Anderson S, et al: Conservative management of intraductal carcinoma (DCIS) of the breast. J Surg Oncol 1991; 47: 139147.
  • 32
    Mamounas E, Fisher B, Dingam J, et al: Effects of breast irradiation following lumpectomy in intraductal carcinoma (DCIS): Updated results from NSABP B-17. Proc Soc Surg Oncol 1997; 50: 7.
  • 33
    Salvadori B, Delledonne V, Rovini D: National Cancer Institute-Milan experience, in SilversteinMJ (ed): Ductal Carcinoma in Situ of the Breast. Baltimore, Williams & Wilkins, 1997, pp 427432.
  • 34
    Shreer I: Conservation therapy of DCIS without radiation. Breast Dis 1996; 9: 2736.
  • 35
    Schwartz GF, Finkel GC, Garcia JC, et al: Subclinical ductal carcinoma in situ of the breast: Treatment by local excision and surveillance alone. Cancer 1992; 70: 24682474.
  • 36
    Schwartz GF: Treatment of subclinical ductal carcinoma in situ by excision and local surveillance, in SilversteinMJ (ed): Ductal Carcinoma in Situ of the Breast. Baltimore, Williams & Wilkins, 1997, pp 353360.
  • 37
    Sibbering DM, Blamey RW: Nottingham experience, in SilversteinMJ (ed): Ductal Carcinoma in Situ of the Breast. Baltimore, Williams & Wilkins, 1997, pp 367372.
  • 38
    Silverstein MJ: Van Nuys experience by treatment, in SilversteinMJ (ed): Ductal Carcinoma in Situ of the Breast. Baltimore, Williams & Wilkins, 1997, pp 443448.
  • 39
    Silverstein MJ, Poller DN, Waisman JR, et al: Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995; 345: 11541157.

Follow-Up Recommendations

  1. References
  2. Selected Bibliography: Mammographic Evaluation
  3. Surgical Considerations
  4. Pathologic Evaluation
  5. Selection of Treatment
  6. Follow-Up Recommendations